• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wellcare to Offer Medicare Advantage and Medicare Prescription Drug Plans in 205 Texas Counties in 2026

    11/10/25 9:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email

    In 2026, Wellcare will also expand coverage for individuals who qualify for both Medicare and Medicaid, providing access to more comprehensive care and benefits

    AUSTIN, Texas, Nov. 10, 2025 /PRNewswire/ -- Wellcare, Wellcare By Allwell, and Wellcare By Superior HealthPlan, the Medicare products offered by Superior HealthPlan, a company of Centene Corporation (NYSE:CNC), will be available in 205 counties across Texas in 2026. This includes the cities of Austin, Dallas, El Paso, Houston, San Antonio and several others. The 2026 Medicare Annual Enrollment Period (AEP) begins Oct. 15, 2025, and runs through Dec. 7, 2025. Texans who enroll by Dec. 7, 2025, will have coverage starting Jan. 1, 2026.

    Wellcare, Wellcare By Allwell, and Wellcare By Superior HealthPlan will be available in Texas in 2026.

    "Superior HealthPlan has proudly delivered quality Medicare coverage to Texans for more than 15 years," said Superior HealthPlan President and CEO, Mitch Wasden. "Throughout that time, we've remained focused on evolving our product offerings and believe our 2026 plans will provide our most comprehensive healthcare coverage yet."

    The company's multi-year journey to maximize Centene's unique market position focuses on creating a seamless integrated experience for Dual Eligible Special Needs Plan (D-SNP) members, caregivers and their providers. Medicare provides coverage primarily based on a member being 65 and older or eligible through disability, while Medicaid typically offers coverage to individuals and families who meet specific income and financial eligibility requirements. Members eligible for both programs are referred to as Dual Eligibles or Duals.

    As part of evolving support and product offerings for D-SNP members, Wellcare will launch the first phase of an enhanced integrated Duals model across eight states, including in Texas. This is part of the broader transition from Medicare-Medicaid Plans (MMPs) to integrated Dual Eligible Special Needs Plans (D-SNPs), effective Jan. 1, 2026. The plan, formally Wellcare Superior HealthPlan Dual Align (HMO D-SNP), will be offered in Dallas and Hidalgo Counties.

    This shift aligns with the conclusion of the Medicare-Medicaid Financial Alignment Initiative (FAI), which phases out MMPs nationwide. Wellcare currently offers MMPs in five of the eight launch states, which includes Texas, and will seamlessly transition members in those markets to new integrated D-SNPs that administer both Medicare and Medicaid benefits.

    This transition is designed to enhance the coordination of care and streamline services for both Medicare and Medicaid eligibles, while delivering improved outcomes. Existing Wellcare dual eligible members enrolled in our MMP or Highly Integrated Dual Eligible Special Needs Plan in the Texas counties of Dallas and Hidalgo will be automatically enrolled in their new integrated D-SNP, unless they opt out and choose another Medicare plan. Members should review their Annual Notice of Change (ANOC) for important updates regarding their coverage and benefits.

    "We are deeply committed to offering a diverse range of plans that support our members' health and well-being," said Wellcare Chief Executive Officer, Michael Carson. "We're especially excited about the continued growth and integration of our Dual Eligible Special Needs Plans, in collaboration with our federal and state partners, which help us better serve individuals who are eligible for both Medicare and Medicaid. Supporting the health of our aging population isn't just a priority – it's a responsibility. These offerings reflect our dedication to delivering quality care, improving health outcomes and creating a seamless experience for some of the most vulnerable populations in our communities."

    The company continues to enhance the member experience by investing in digital tools and resources for both current and prospective members. This includes:

    • Delivering a modernized, supportive and engaging onboarding experience to new and renewing members.
    • Providing member onboarding videos in eight languages: Spanish, Vietnamese, Russian, Tagalog, Chinese Traditional, Chinese Taiwan, Chinese Hong Kong and Korean.
    • Initiating and maintaining communication with members to help them understand their  benefits, including available services and provider options.
    • Leveraging data, analytics and technology to measure our operational performance and adjust to meet members' needs and improve overall experience.
    • Conducting frequent member surveys to better understand what matters most to them and where we can improve to make their experience better.

    For more details about Wellcare's MA plans visit WellcareNow.com and for more details about Medicare Prescription Drug Plans (PDP) visit pdpwellcare.com.

    Wellcare's 2026 Plan Offerings

    For 2026, Wellcare will offer plans to more than 51 million beneficiaries across the nation, which accounts for more than 75% of the eligible beneficiaries in 32 states and more than 1,850 counties. Wellcare has added 51 counties to its footprint across the following states: California, Illinois, Iowa, Kansas, Michigan, Nevada, North Carolina and Texas.

    Medicare Advantage Prescription Drug (MAPD) Plan Highlights:

    In 2026, a variety of plan offerings for value-conscious beneficiaries are available with predictable copays and extra benefits:

    • The Wellcare Spendables® card continues to offer eligible members a single card with preloaded funds available at more than 66,000 nationwide retailers across Wellcare's 32-state footprint. Eligible members may use their Wellcare Spendables® card on multiple benefits. Depending on the plan, benefits may include an allowance for over-the-counter health items and covered out-of-pocket dental, vision and hearing costs. Members who are eligible may use the allowance for other benefits to support their overall well-being. Additionally, an integrated experience combines the Wellcare Spendables® card and Wellcare Rewards™ programs into one platform.
      • Members earn rewards for health actions, including annual preventive visits, using the member portal, flu shots and health screenings.
      • As the Value-Based Insurance Design (VBID) program phases out, extra benefits  such as help with groceries, gas, rent and, utilities will now be available through a different program for members who meet specific health conditions. We've simplified the process so members can more easily check their eligibility. Members who aren't eligible for additional benefits will be limited to certain types of care, like over-the-counter items or out-of-pocket medical costs.
    • $0 or low copay for primary care physician visits on all plans.
    • Dario's digital mental health and social support resources (formerly Twill Therapeutics) provide online behavioral health support and is available 24/7 across all Medicare Advantage (MA) plans. Services include peer-to-peer support, self-guided behavioral health programs and access to Centene health plan resources.
    • Monthly cost for insulin under Medicare plans will be capped at either $35 or 25% of the drug's negotiated or maximum fair price, whichever is lower.
    • $0 cost-sharing for Part D vaccinations recommended for adults by the Advisory Committee on Immunization Practices (ACIP).
    • The Part D benefit will continue to consist of three phases with members' out-of-pocket costs capped at no more than $2,100 for the plan year.
    • Preferred retail pharmacy networks will include Walgreens*, CVS* and select grocers*. A robust network is expected with access to more than 60,000 total pharmacies nationwide.
    • Express Scripts® Pharmacy home delivery will continue to be the preferred mail order (Home Delivery) pharmacy focusing on providing convenient and efficient service for prescriptions that are filled for more than 35 days.
    • Benefits also include $0 for: routine physical exams to support annual preventive visits; kidney evaluation and A1c labs; preventive and diagnostic mammograms; preventive and diagnostic colonoscopies; routine/medical eye exams for diabetics; and Tier 6 adherence meds at preferred pharmacies.

    Medicare Prescription Drug Plans (PDP) Highlights:

    Wellcare's Prescription Drug Plans (PDP) will continue to be available nationwide with competitive benefits:  

    • Two products (Classic and Value Script) will be offered in all 34 regions across all 50 states and the District of Columbia; 68 PDPs nationwide.
    • We continue to offer products to meet the unique needs of Medicare beneficiaries including:
      • Dual eligibles; and
      • Low premium "value" shoppers
    • A competitive formulary design will be offered across both plans.
    • The Value Script plan will continue to offer members a cost-effective option, with one of the lowest premiums in the nation.
    • The Classic plan will be under the Centers for Medicare and Medicaid Services (CMS) benchmark in all regions making this plan a great option for members receiving a Low-Income Subsidy (LIS).  
    • Both plans feature a $0 copay on Tier 1 (Preferred Generic) prescriptions when filled at a preferred pharmacy.

    About Wellcare

    Wellcare offers a range of Medicare products, including Medicare Advantage and Medicare Prescription Drug Plans (PDP), which offer affordable coverage beyond Original Medicare. Wellcare is the Medicare brand of Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. Beginning Jan. 1, 2022, Centene's Medicare brands, including Allwell, Health Net, Fidelis Care, Trillium Advantage, 'Ohana Health Plan and TexanPlus transitioned to the Wellcare brand. For more information about Wellcare, visit www.wellcare.com. 

    Benefits and allowance amounts vary by plan. Please call for more details. Allowance amounts cannot be combined with other benefit allowances which may be on the prepaid card. Limitations and restrictions may apply.

    Wellcare is the Medicare brand for Centene Corporation, an HMO, PPO, PFFS, PDP plan with a Medicare contract and is an approved Part D Sponsor. Our D-SNP plans have a contract with the state Medicaid program. Enrollment in our plans depends on contract renewal. Benefits mentioned are a part of Special Supplemental Benefits for the Chronically Ill. Not all members will qualify. In addition to being high-risk, you must have one or more of the following chronic conditions: cancer, cardiovascular disorders, chronic and disabling mental health conditions, chronic lung disorders, diabetes. There are other eligible conditions not listed. Eligibility for this benefit cannot be guaranteed based solely on your condition. All applicable eligibility requirements must be met before the benefit is provided. For details, please contact us or see the plan's Evidence of Coverage/Member Handbook. Texas D-SNP prospective enrollees: For detailed information about Texas Medicaid benefits, please visit the Texas Medicaid website at https://www.hhs.texas.gov/services/health/medicaid-chip/medicaid-chip-members/starplus. To request a written copy of our Medicaid Provider Directory, please contact us. Wellcare (HMO, HMO SNP, and PPO) includes products that are underwritten by WellCare of Texas, Inc., WellCare National Health Insurance Company, Superior HealthPlan, Inc., and SelectCare of Texas, Inc.

    *Other Pharmacies/Physicians/Providers are available in our network.

    H0062_WCM_4749234E_M FINAL1 Approved 11072025

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/wellcare-to-offer-medicare-advantage-and-medicare-prescription-drug-plans-in-205-texas-counties-in-2026-302609441.html

    SOURCE Superior HealthPlan

    Get the next $CNC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    10/14/2025$33.00Sell
    Goldman
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    7/21/2025$33.00Buy → Hold
    TD Cowen
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    7/2/2025$48.00Overweight → Neutral
    Analyst
    More analyst ratings

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CENTENE CORP (0001071739) (Filer)

    11/10/25 4:40:53 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

    SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)

    11/5/25 11:30:18 AM ET
    $CNC
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Centene Corporation

    10-Q - CENTENE CORP (0001071739) (Filer)

    10/28/25 7:59:02 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sacramento Youth Gain Mentorship and New Career Pathways through $100,000 Health Net Grant to Sacramento County Office of Education

    The investment backs a peer-mentorship convening and a new online workforce map to create clear pathways into mental-health jobs for local youth SACRAMENTO, Calif., Nov. 12, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE:CNC), has awarded a $100,000 grant to the Sacramento County Office of Education (SCOE) to support two ground breaking initiatives aimed at improving youth behavioral health and strengthening the local mental health workforce pipeline. The investment will fund a

    11/12/25 12:00:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    Wellcare Announces 2026 Annual Enrollment Period in Florida: Choose the Right Medicare Coverage That Works for You

    Wellcare Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Wellcare, a Centene Corporation (NYSE: CNC) company offering a comprehensive range of Medicare products, is excited to announce the start of the 2026 Medicare Annual Enrollment Period (AEP), from Oct. 15, 2025, through Dec. 7, 2025. "Choosing the right Medicare plan is one of the most important decisions seniors make each year," said Charlene Zein, CEO of Sunshine Health

    11/12/25 8:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026

    Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide New in 2026 Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstrations to integrated Dual Eligible Special Needs Plans (D-SNPs) in five states COLUMBIA, S.C., Nov. 10, 2025 /PRNewswire/ -- Wellcare, a company offering a comprehensive range of Medicare products and the Medicare brand of Centene Corporation (NYSE:CNC), will offer Medicare Advantage (MA) to over 51 million beneficiaries in 32 states and Prescription Drug Plan (PDP) products to more than 8 million members across all 50 states. This includes 51 new counties across

    11/10/25 5:33:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Samuels Theodore R. Ii was granted 710 shares, increasing direct ownership by 4% to 19,205 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    10/1/25 5:47:05 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Tanji Kenneth was granted 803 shares, increasing direct ownership by 16% to 5,948 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    10/1/25 5:47:11 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Eppinger Frederick H was granted 710 shares, increasing direct ownership by 0.20% to 359,753 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    10/1/25 5:46:59 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Centene with a new price target

    Goldman initiated coverage of Centene with a rating of Sell and set a new price target of $33.00

    10/14/25 8:47:32 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00

    7/28/25 8:33:52 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Centene from Overweight to Equal Weight and set a new price target of $30.00

    7/23/25 7:38:36 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    2/24/25 4:15:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS

    -- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the

    10/29/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL CALL SCHEDULED FOR 9AM ET

    ST. LOUIS, Sept. 29, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 third quarter financial results at approximately 6:00 a.m. ET on Wednesday, October 29, 2025, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 0266211 to ex

    9/29/25 9:57:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS

    -- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) -- ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $             48,742 Premium and service revenues (in millions) $             42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjusted SG&A expense ratio (1) 7.1 % GAAP diluted loss per share $                (0.51) Adjusted diluted loss per share (1) $                (0.16) Total cash flow provided by operations (in millions) $              

    7/25/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care